• Menu
  • Skip to left header navigation
  • Skip to right header navigation
  • Skip to main content
  • Skip to primary sidebar

Before Header

  • Bluesky
  • Facebook
  • Instagram
  • TikTok
  • Twitter
  • YouTube

Buzz

Journalism & News from Bournemouth University

  • News
    • Campus
    • Local
    • National
    • World
    • Entertainment
    • Lifestyle
    • Technology
    • Sustainability
  • Sport
    • AFC Bournemouth
    • Boxing
    • Cricket
    • Formula 1
    • Golf
    • Local Football
    • Men’s Football
    • Opinion & Analysis
    • Rugby League
    • Rugby Union
    • Tennis
  • Watch
    • Interactive
      • 2022 iDocs
      • 2021 iDocs
      • 2020 iDocs
      • 2019 iDocs
      • 2018 iDocs
      • 2017 iDocs
      • 2016 iDocs
      • 2015 iDocs
    • Documentary
      • 2018 Docs
      • 2017 Docs
      • 2016 Docs
      • 2015 Docs
      • 2014 Docs
  • Search
  • Elections
    • US2024
    • UK2019
    • US2016
    • UK2015
    • US2012
  • About
    • Authors
    • Archive
  • Sites
    • The Breaker
    • The Rock
  • News
    • Campus
    • Local
    • National
    • World
    • Entertainment
    • Lifestyle
    • Technology
    • Sustainability
  • Sport
    • AFC Bournemouth
    • Boxing
    • Cricket
    • Formula 1
    • Golf
    • Local Football
    • Men’s Football
    • Opinion & Analysis
    • Rugby League
    • Rugby Union
    • Tennis
  • Watch
    • Interactive
      • 2022 iDocs
      • 2021 iDocs
      • 2020 iDocs
      • 2019 iDocs
      • 2018 iDocs
      • 2017 iDocs
      • 2016 iDocs
      • 2015 iDocs
    • Documentary
      • 2018 Docs
      • 2017 Docs
      • 2016 Docs
      • 2015 Docs
      • 2014 Docs
  • Elections
    • US2012
    • US2016
    • UK2015
    • UK2019
  • About
    • Authors
    • Archive
  • Sites
    • The Breaker
    • The Rock

Mobile Menu

  • Bluesky
  • Facebook
  • Instagram
  • TikTok
  • Twitter
  • YouTube

AstraZeneca scraps £450m UK investment plan

January 31, 2025 //  by Brad Duff

Image courtesy of MasterTux via Pexels

Pharmaceutical giant AstraZeneca has announced its decision to forgo plans to invest £450m into expanding a vaccine manufacturing plant in Merseyside, blaming a reduction in support in comparison to the previous government.

“The timing and reduction of the final offer compared to the previous government’s proposal,”

This comes just two days after Chancellor Rachel Reeves’ plan to go “further and faster” to boost economic growth was set out.

AstraZeneca said tat the site will continue to produce and supply flu vaccines for patients in the UK and “around the world.” They also stated that no current jobs at the site would be affected.





About Brad Duff

I am a Journalist studying Multimedia Journalism at BU. My main area of interest and expertise in in sports, specifically American football. I love the idea of increasing the popularity of the sport in the UK and Europe and would love to play a part in its growth through the art of journalism.

View all posts by Brad Duff

Category: Health, News, News TopTag: government, health

Previous Post: « Carer jailed for sexually assaulting woman in her own home
Next Post: Operation Nightingale: Unearthing History and Healing Paul digging by Paul Hemingway»

Site Footer

  • Login
  • Privacy Policy
  • User Guides
  • Writer’s Guide

Copyright © 2025 Buzz · All Rights Reserved · Powered by Mai Theme

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok